Table 4 |
||||
|
Proportions of TERC/C-MYC amplification types in cervical disorders |
||||
|
TERC positive |
C-MYC positive |
|||
|
|
||||
|
Histological diagnosis |
CIN2+ |
Normal/CIN1 |
CIN2+ |
Normal/CIN1 |
|
|
||||
|
Case no. |
45 |
20 |
40 |
43 |
|
Abnormal nuclei (no.) |
963 |
213 |
854 |
293 |
|
Abnormal nuclei (%) |
21.1 |
10.2 |
20.9 |
6.2 |
|
Distribution of GCN (%) |
||||
|
3 copies |
27.7 |
55.9 |
48.0 |
49.5 |
|
4 copies |
31.9 |
25.4 |
35.5 |
39.9 |
|
5 copies |
16.5 |
10.8 |
9.6 |
7.2 |
|
6 copies |
7.1 |
5.6 |
3.9 |
1.7 |
|
≥ 7 copies |
16.8 |
2.3 |
3.0 |
1.7 |
|
Distribution of TERC: CEP3 ratios (%) |
||||
|
< 1 |
4.0 |
5.2 |
||
|
= 1 |
26.9 |
33.8 |
||
|
> 1 |
69.1 |
61.0 |
||
|
|
||||
|
Chen et al. Diagnostic Pathology 2012 7:40 doi:10.1186/1746-1596-7-40 |
||||
